» Articles » PMID: 24185619

Immunobiology of Mesenchymal Stem Cells

Overview
Specialty Cell Biology
Date 2013 Nov 5
PMID 24185619
Citations 379
Authors
Affiliations
Soon will be listed here.
Abstract

Mesenchymal stem cells (MSCs) can be isolated from almost all tissues and effectively expanded in vitro. Although their true in situ properties and biological functions remain to be elucidated, these in vitro expanded cells have been shown to possess potential to differentiate into specific cell lineages. It is speculated that MSCs in situ have important roles in tissue cellular homeostasis by replacing dead or dysfunctional cells. Recent studies have demonstrated that in vitro expanded MSCs of various origins have great capacity to modulate immune responses and change the progression of different inflammatory diseases. As tissue injuries are often accompanied by inflammation, inflammatory factors may provide cues to mobilize MSCs to tissue sites with damage. Before carrying out tissue repair functions, MSCs first prepare the microenvironment by modulating inflammatory processes and releasing various growth factors in response to the inflammation status. In this review, we focus on the crosstalk between MSCs and immune responses and their potential clinical applications, especially in inflammatory diseases.

Citing Articles

Hierarchical TiO nanotube arrays enhance mesenchymal stem cell adhesion and regenerative potential through surface nanotopography.

Tasdemir N, Kilicarslan B, Imren G, Karaosmanoglu B, Taskiran E, Bayram C J R Soc Interface. 2025; 22(223):20240642.

PMID: 39999880 PMC: 11858746. DOI: 10.1098/rsif.2024.0642.


Mesenchymal stem cells and their extracellular vesicle therapy for neurological disorders: traumatic brain injury and beyond.

Yarahmadi A, Dorri Giv M, Hosseininejad R, Rezaie A, Mohammadi N, Afkhami H Front Neurol. 2025; 16:1472679.

PMID: 39974358 PMC: 11835705. DOI: 10.3389/fneur.2025.1472679.


Decoding Cytokine Dynamics: Wharton's Jelly Stromal Cells and Chondro-Differentiates in PHA-Stimulated Co-Culture.

Meenakshi Sundaram R, Rupert S, Srinivasan P, Sathyanesan J, Govarthanan K, Jeyaraman N Cells. 2025; 14(3).

PMID: 39936966 PMC: 11817647. DOI: 10.3390/cells14030174.


Artificial intelligence (AI)-powered bibliometric analysis of global trends in mesenchymal stem cells (MSCs)-derived exosome research: 2014-2023.

Tsai S, Wan B, Tsai F, Yang J Biomedicine (Taipei). 2025; 14(4):61-77.

PMID: 39777112 PMC: 11703396. DOI: 10.37796/2211-8039.1470.


Mechanisms underlying the involvement of peritoneal macrophages in the pathogenesis and novel therapeutic strategies for dialysis-induced peritoneal fibrosis.

Wang Y, Zhang Y, Ma M, Zhuang X, Lu Y, Miao L Front Immunol. 2025; 15:1507265.

PMID: 39749340 PMC: 11693514. DOI: 10.3389/fimmu.2024.1507265.


References
1.
FRIEDENSTEIN A, Chailakhyan R, Latsinik N, Panasyuk A . Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation. 1974; 17(4):331-40. DOI: 10.1097/00007890-197404000-00001. View

2.
Groh M, Maitra B, Szekely E, Koc O . Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Exp Hematol. 2005; 33(8):928-34. DOI: 10.1016/j.exphem.2005.05.002. View

3.
Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts A . Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell. 2008; 2(2):141-50. DOI: 10.1016/j.stem.2007.11.014. View

4.
Spaggiari G, Abdelrazik H, Becchetti F, Moretta L . MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood. 2009; 113(26):6576-83. DOI: 10.1182/blood-2009-02-203943. View

5.
Hung S, Yang M, Tseng K, Lee O . Hypoxia-induced secretion of TGF-β1 in mesenchymal stem cell promotes breast cancer cell progression. Cell Transplant. 2012; 22(10):1869-82. DOI: 10.3727/096368912X657954. View